Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 844

Results For "X"

9444 News Found

Biotium introduces unique super-sensitive RNA Prestain Loading Dye
Biotech | January 06, 2022

Biotium introduces unique super-sensitive RNA Prestain Loading Dye

EMBER500RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels


Thermo Fisher Scientific acquires PeproTech for US $1.85 bn
Medical Device | January 06, 2022

Thermo Fisher Scientific acquires PeproTech for US $1.85 bn

PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products


NATHEALTH Home Care Forum launches white paper on healthcare delivery
Healthcare | January 06, 2022

NATHEALTH Home Care Forum launches white paper on healthcare delivery

10 implementation focused initiatives recommended to accelerate policy reforms, standardization of home care delivery services, and improve accessibility and affordability of care in tier II and tier III geographies


ENTOD Pharmaceuticals set to launch Molentod
News | January 06, 2022

ENTOD Pharmaceuticals set to launch Molentod

It is the generic version of molnupiravir


Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
People | January 05, 2022

Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India

He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management


Tata Medical develops OmiSure to detect Omicron
Medical Device | January 05, 2022

Tata Medical develops OmiSure to detect Omicron

The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes


Jemincare confirms its antibody effective against Omicron
Biotech | January 05, 2022

Jemincare confirms its antibody effective against Omicron

The latest research results indicated that JMB2002 had high binding activity to the Omicron variant and showed potent Omicron pseudovirus neutralization function


Bharat Biotech's intranasal vaccine Phase 3 trials gets approval
News | January 05, 2022

Bharat Biotech's intranasal vaccine Phase 3 trials gets approval

It has also been granted permission to conduct trials for booster dose


USFDA grants ILiAD Biotechnologies Fast Track Designation for pertussis vaccine
Biotech | January 04, 2022

USFDA grants ILiAD Biotechnologies Fast Track Designation for pertussis vaccine

BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development


Kyverna Therapeutics announces licence agreement with NIH
Biotech | January 04, 2022

Kyverna Therapeutics announces licence agreement with NIH

This next-generation CAR T construct was designed to improve the tolerability profile of conventional CD19 CAR Ts and developed in the laboratory of James N. Kochenderfer, M.D., at the National Cancer Institute, part of the NIH, the same laboratory that discovered axicabtagene ciloleucel